December 20, 2024
New Delhi, India
Upcoming IPO
Singapore-based foreign institutional investor (FII) Amansa Investments Limited has made a ₹40 crore investment in Hyderabad-based Standard Glass Lining Technology Limited through private placement ahead of the company’s IPO.
Investment Details
- Equity Shares Issued: 28,57,142 shares at ₹140 each (face value ₹10; premium ₹130).
- Stake Acquired: 1.55% of the company’s pre-offer share capital.
- Announcement Date: December 17, 2024.
This pre-IPO funding was secured in consultation with the lead bankers and adds to the company’s financial strength ahead of its public offering.
IPO Details
- DRHP Filed: July 2024.
- IPO Size: Fresh issue of shares worth ₹250 crore and an offer for sale of up to 18,444,000 equity shares.
- SEBI Approval: Received in October 2024.
Business Overview
Standard Glass Lining Technology Limited specializes in engineering solutions for pharmaceutical and chemical industries.
- Products: Includes reaction systems, storage systems, drying systems, and turnkey solutions.
- Portfolio: 65+ products, with over 11,000 units delivered in the past decade.
- Customer Base: 443 clients across pharmaceuticals, chemicals, paints, biotechnology, and food & beverage sectors.
Prominent Clients:
- Aurobindo Pharma, Cadila Pharmaceuticals, Laurus Labs, Granules India, and Natco Pharma are among its notable customers.
IPO Book-Running Lead Managers:
- IIFL Securities Limited and Motilal Oswal Investment Advisors Limited.
- Registrar: KFin Technologies Limited.
Breaking News: Rupee Hits Record Low of ₹85 Against US Dollar
Disclaimer:
CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.
